Complete Filing Data
MDB Capital Holdings, LLC reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $60.58 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean MDB Capital Holdings, LLC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$21.2M | $11.7M | -$7.0M | -$5.3M |
| Other General And Administrative Expense | $2.2M | $2.6M | $1.5M | $1.0M |
| Operating Income Loss | $4.9M | $2.2M | $6.0M | $1.2M |
| Net Operating Income Loss | -$17.7M | -$28.6M | -$8.5M | -$6.1M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$17.0M | $12.0M | -$7.6M | -$5.9M |
| General And Administrative Expense | $22.6M | $29.3M | $14.0M | $7.0M |
| Net Income Loss Attributable To Noncontrolling Interest | -$21.0K | -$90.0K | -$742.9K | -$561.0K |
| Research And Development Expense | $1.5M | $528.2K | $348.1K | |
| Research And Development Grants | $0.00 | $2.0M | $3.0M | $2.3M |
| Income Tax Expense Benefit | $11.0K | $2.0K | $127.9K | |
| Other Nonoperating Income | $617.0K | $1.2M | $919.3K | |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investment | -$17.0M | $12.0M | -$7.7M | |
| Other Nonoperating Expense | $1.1M | $1.1M | ||
| Operating Expenses | $14.5M | $7.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$4.7M | -$8.2M | -$6.6M | -$7.7M | -$4.3M | -$7.2M | -$3.0M | $3.5M | -$1.9M | -$2.2M | -$1.7M | -$1.1M |
| Other General And Administrative Expense | $510.5K | $544.6K | $619.3K | $633.8K | $669.6K | $669.1K | $327.9K | $251.3K | $304.1K | $406.5K | $503.1K | |
| Operating Income Loss | $1.3M | -$1.9M | $828.1K | -$614.2K | $2.3M | -$660.4K | -$3.3M | $3.5M | $117.0K | $74.0K | $12.2K | |
| Net Operating Income Loss | -$3.8M | -$7.4M | -$5.9M | -$8.7M | -$5.1M | -$7.9M | -$775.4K | $5.7M | -$2.2M | -$2.2M | -$1.7M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.6M | -$7.1M | -$5.7M | -$8.4M | -$4.8M | -$7.6M | -$3.1M | $3.7M | -$2.0M | -$2.2M | -$1.7M | |
| General And Administrative Expense | $5.0M | $5.5M | $6.7M | $7.4M | $7.2M | $7.0M | $2.5M | $2.2M | $2.2M | $2.2M | $1.7M | |
| Net Income Loss Attributable To Noncontrolling Interest | -$2.0K | -$14.4K | -$705.1K | -$531.4K | -$393.9K | -$177.9K | -$69.6K | -$94.2K | -$144.7K | -$121.0K | ||
| Research And Development Expense | $723.5K | $237.4K | $277.6K | $27.9K | $7.6K | $31.6K | $103.6K | -$9.1K | ||||
| Research And Development Grants | $0.00 | $0.00 | $0.00 | $489.8K | $609.2K | $793.5K | $743.3K | $767.7K | $793.5K | |||
| Income Tax Expense Benefit | $2.1K | $63.6K | $320.6K | |||||||||
| Other Nonoperating Income | $147.1K | $175.3K | $180.6K | $279.1K | $321.0K | $337.9K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investment | -$3.6M | -$7.1M | -$5.7M | -$8.4M | -$4.8M | -$7.6M | ||||||
| Other Nonoperating Expense | $320.3K | $273.8K | $254.0K | $301.7K | $514.8K | $167.8K | ||||||
| Operating Expenses | $7.3M | $2.5M | $2.2M | $2.3M | $2.3M | $1.7M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity * | $60.7M | $70.2M | $37.3M | $22.6M | $6.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $15.5M | $21.3M | $7.4M | $5.0M | $6.2M |
| Unrealized Gain Loss On Investments | -$246.0K | -$275.0K | $1.5M | $15.4K | |
| Minority Interest | -$111.0K | -$90.0K | $7.3K | $468.7K | |
| Grants Receivable | $882.3K | $809.5K | $468.4K | ||
| Retained Earnings Accumulated Deficit | -$19.8M | $1.4M | -$12.1M | -$5.1M | |
| Property Plant And Equipment Net | $117.0K | $90.0K | $866.5K | $624.6K | |
| Prepaid Expense And Other Assets Current | $433.0K | $513.0K | $523.8K | $309.8K | |
| Preferred Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | |
| Operating Lease Right Of Use Asset | $547.0K | $641.0K | $2.3M | $1.4M | |
| Operating Lease Liability | $609.0K | $711.0K | $2.4M | $1.4M | |
| Liabilities And Stockholders Equity | $63.7M | $72.0M | $43.0M | $25.7M | |
| Liabilities | $3.2M | $1.9M | $5.7M | $2.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$5.7M | $13.9M | $2.4M | -$1.3M | |
| Cash And Cash Equivalents At Carrying Value | $13.2M | $20.4M | $6.1M | $5.0M | |
| Assets | $63.7M | $72.0M | $43.0M | $25.7M | |
| Accrued Liabilities Current And Noncurrent | $95.0K | $72.0K | $1.1M | $254.7K | |
| Cash And Securities Segregated Under Securities Exchange Commission Regulation | $2.3M | $844.0K | $1.2M | ||
| Cash And Securities Segregated Under Federal And Other Regulations | $2.3M | $844.0K | $1.2M | ||
| Operating Lease Right Of Use Asset Amortization Expense | $95.0K | $1.7M | |||
| Accretion Of Investments At Amortized Cost US Treasury Bills | $534.0K | $710.6K | |||
| Available For Sale Securities Debt Securities | $5.9M | $5.8M | $832.6K | ||
| Accretion Of Deferred Grant Reimbursement | -$38.9K | ||||
| Accounts Payable Current And Noncurrent | $267.0K | $324.0K | $578.2K | $698.8K | |
| Payables To Noncustomers | $1.4M | ||||
| Deferred Offering Costs | $69.3K | $323.2K | |||
| Payment Of Deferred Costs Of Initial Public Offering | $69.3K | $323.2K | |||
| Equity Method Investments | $37.5M | $41.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $59.7M | $61.9M | $67.1M | $29.0M | $33.0M | $33.8M | $39.0M | $24.2M | $21.2M | $23.7M | $25.9M | $2.7M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $15.9M | $17.9M | $20.0M | $18.3M | $20.5M | $8.5M | $26.4M | $2.4M | $3.5M | $11.6M | $28.4M | |||
| Unrealized Gain Loss On Investments | $1.2M | -$2.2M | -$1.5M | -$718.5K | $899.5K | -$747.3K | -$786.9K | $1.4M | $54.8K | $16.1K | -$35.6K | |||
| Minority Interest | -$106.1K | -$106.1K | -$104.1K | -$814.6K | -$427.0K | -$243.8K | $301.4K | $418.0K | $704.6K | $823.0K | $522.2K | |||
| Grants Receivable | $554.0K | $1.1M | $1.1M | $676.5K | $1.1M | $1.0M | $838.9K | $721.8K | ||||||
| Retained Earnings Accumulated Deficit | -$18.0M | -$13.4M | -$5.1M | -$31.3M | -$23.6M | -$19.3M | -$6.3M | -$3.5M | ||||||
| Property Plant And Equipment Net | $99.2K | $79.2K | $84.8K | $835.8K | $910.3K | $946.9K | $842.3K | $580.1K | ||||||
| Prepaid Expense And Other Assets Current | $259.7K | $384.7K | $473.7K | $428.7K | $488.9K | $494.5K | $561.5K | $232.9K | ||||||
| Preferred Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Operating Lease Right Of Use Asset | $571.0K | $594.9K | $618.4K | $2.1M | $2.1M | $2.2M | $2.1M | $1.5M | ||||||
| Operating Lease Liability | $635.4K | $661.7K | $686.9K | $2.2M | $2.3M | $2.3M | $2.2M | $1.6M | ||||||
| Liabilities And Stockholders Equity | $61.5M | $63.5M | $68.6M | $34.2M | $37.7M | $40.9M | $43.5M | $27.4M | ||||||
| Liabilities | $1.9M | $1.7M | $1.6M | $6.0M | $5.1M | $7.4M | $4.1M | $2.8M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$1.3M | $1.1M | -$1.5M | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $15.1M | $17.1M | $19.6M | $16.7M | $17.5M | $5.5M | $24.4M | $2.4M | ||||||
| Assets | $61.5M | $63.5M | $68.6M | $34.2M | $37.7M | $40.9M | $43.5M | $27.4M | ||||||
| Accrued Liabilities Current And Noncurrent | $59.1K | $72.0K | $170.7K | $304.3K | $147.4K | $515.9K | $154.3K | $106.1K | ||||||
| Cash And Securities Segregated Under Securities Exchange Commission Regulation | $837.6K | $783.6K | $471.4K | $1.6M | $3.0M | $3.0M | ||||||||
| Cash And Securities Segregated Under Federal And Other Regulations | $837.6K | $783.6K | $471.4K | $1.6M | $3.0M | $3.0M | ||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $23.0K | $84.6K | $57.1K | |||||||||||
| Accretion Of Investments At Amortized Cost US Treasury Bills | $305.0K | $187.3K | ||||||||||||
| Available For Sale Securities Debt Securities | $5.6M | $6.3M | $5.0M | $5.0M | $5.8M | |||||||||
| Accretion Of Deferred Grant Reimbursement | -$13.2K | $13.0K | ||||||||||||
| Accounts Payable Current And Noncurrent | $329.1K | $285.1K | $376.0K | $1.0M | $678.8K | |||||||||
| Payables To Noncustomers | $41.00 | $21.00 | $986.4K | $2.4M | ||||||||||
| Deferred Offering Costs | $587.4K | $351.5K | $266.9K | $728.3K | ||||||||||
| Payment Of Deferred Costs Of Initial Public Offering | $91.5K | $272.3K | ||||||||||||
| Equity Method Investments | $38.7M | $39.8M | $40.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Share Based Compensation | $11.8M | $14.4M | $4.4M | $218.4K |
| Net Cash Provided By Used In Operating Activities | -$5.7M | -$9.0M | -$7.1M | -$6.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$55.0K | -$11.0K | $474.0K | $67.1K |
| Increase Decrease In Accrued Liabilities | $22.0K | -$1.0M | $850.3K | $225.0K |
| Net Cash Provided By Used In Investing Activities | -$49.0K | $22.9M | -$8.2M | -$16.4M |
| Net Cash Provided By Used In Financing Activities | $69.0K | $17.8M | $21.7M | |
| Increase Decrease In Other Receivables | -$882.0K | $72.8K | $341.2K | |
| Stock Issued During Period Value Share Based Compensation | $14.4M | $4.4M | $218.4K | |
| Payments To Acquire Property Plant And Equipment | $438.8K | $193.3K | ||
| Increase Decrease In Other Accounts Payable | $58.0K | -$252.0K | -$120.8K | |
| Depreciation Depletion And Amortization | $22.0K | $230.0K | $196.9K | $147.8K |
| Increase Decrease In Operating Lease Liability | -$103.0K | -$1.7M | ||
| Increase Decrease In Payables To Noncustomers | -$1.4M | $1.4M | ||
| Increase Decrease In Payables To Customers | $1.4M | $772.0K | ||
| Increase Decrease In Deposit Other Assets | $262.0K | $1.5M | ||
| Increase Decrease In Deferred Revenue | -$20.0K | $20.0K | ||
| Proceeds From Warrants Issued As Part Of Investment Banking Deal | $297.0K | $165.1K | ||
| Proceeds From Sale Of Investment Securities At Fair Value | $632.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $3.5M | $3.8M | $54.1K | |||||
| Net Cash Provided By Used In Operating Activities | -$1.3M | -$2.3M | -$1.2M | |||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$39.5K | $76.8K | -$39.8K | |||||
| Increase Decrease In Accrued Liabilities | $98.5K | -$589.2K | -$105.5K | |||||
| Net Cash Provided By Used In Investing Activities | $3.4M | -$55.3K | ||||||
| Net Cash Provided By Used In Financing Activities | -$91.5K | -$272.3K | ||||||
| Increase Decrease In Other Receivables | $229.3K | $203.1K | ||||||
| Stock Issued During Period Value Share Based Compensation | $3.5M | $3.8M | $349.4K | $59.0K | $54.1K | $54.1K | $56.0K | $54.1K |
| Payments To Acquire Property Plant And Equipment | $143.2K | $6.9K | ||||||
| Increase Decrease In Other Accounts Payable | $52.1K | $338.6K | $399.4K | |||||
| Depreciation Depletion And Amortization | $62.8K | $44.1K | ||||||
| Increase Decrease In Operating Lease Liability | -$24.6K | -$75.9K | -$19.3K | |||||
| Increase Decrease In Payables To Noncustomers | -$41.00 | $1.2M | ||||||
| Increase Decrease In Payables To Customers | -$399.7K | $871.9K | ||||||
| Increase Decrease In Deposit Other Assets | -$722.7K | $443.7K | ||||||
| Increase Decrease In Deferred Revenue | ||||||||
| Proceeds From Warrants Issued As Part Of Investment Banking Deal | -$990.4K | |||||||
| Proceeds From Sale Of Investment Securities At Fair Value | $25.1K | $776.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Professional Fees | $1.9M | $3.1M | $1.7M | $1.7M |
| Other Operating Income | $861.0K | $411.0K | $308.3K | $88.5K |
| Communications And Information Technology | $1.1M | $922.0K | $602.4K | $348.6K |
| Clearing And Other Charges | $556.0K | $1.1M | $390.0K | $16.1K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.8M | $14.4M | ||
| Operating Expense Related Party | $1.8M | $1.5M | $1.1M | |
| Operating Costs And Expenses | $22.6M | $30.8M | $14.5M | |
| Compensation Costs | $15.0M | $20.1M | $8.6M | |
| Additional Paid In Capital | $80.5M | $68.7M | $49.4M | $27.8M |
| Fee Income | $4.3M | $2.2M | $4.2M | $1.1M |
| Interest And Other Income | $919.3K | $227.2K | ||
| Warrants Received As Part Of Investment Banking Deal | $657.0K | $2.5M | ||
| Income Recognized From Warrants Received | $1.9M | $659.0K | $2.6M | |
| Held To Maturity Securities Fair Value | $24.7M | $16.2M | ||
| Labor And Related Expense | $8.6M | $2.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $423.1K | $352.0K | $788.7K | $850.0K | $640.6K | $919.1K | $459.6K | $176.8K | $604.7K | $51.0K | $285.7K |
| Other Operating Income | $25.6K | $292.6K | $150.7K | $104.2K | $85.5K | $86.9K | $11.5K | $67.2K | $62.2K | $57.9K | $47.8K |
| Communications And Information Technology | $291.6K | $267.8K | $249.9K | $236.5K | $209.4K | $206.0K | $93.3K | $168.1K | $147.4K | $93.5K | $65.0K |
| Clearing And Other Charges | $15.9K | $35.1K | $288.6K | $876.00 | $226.4K | $2.0K | $3.3K | $368.9K | $10.8K | $2.5K | $2.5K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.5M | $3.0M | $3.5M | $4.1M | $3.8M | $3.8M | $349.4K | $59.0K | $54.1K | ||
| Operating Expense Related Party | $447.9K | $473.5K | $455.4K | $490.0K | $305.0K | $320.3K | $273.8K | $254.0K | |||
| Operating Costs And Expenses | $5.0M | $5.5M | $6.7M | $8.1M | $7.4M | $7.3M | $2.5M | $2.2M | |||
| Compensation Costs | $3.3M | $3.8M | $4.3M | $5.2M | $5.1M | $4.9M | $1.3M | $973.7K | |||
| Additional Paid In Capital | $77.8M | $75.3M | $72.2M | $60.3M | $56.6M | $53.1M | $45.3M | $27.8M | |||
| Fee Income | $2.1M | $1.3M | $4.2M | ||||||||
| Interest And Other Income | $279.1K | $321.0K | $337.9K | $176.3K | $184.9K | $187.3K | |||||
| Warrants Received As Part Of Investment Banking Deal | $990.4K | ||||||||||
| Income Recognized From Warrants Received | |||||||||||
| Held To Maturity Securities Fair Value | $5.1M | $5.0M | $21.4M | $7.5M | $14.9M | ||||||
| Labor And Related Expense | $4.9M | $1.3M | $973.7K | $872.0K | $1.1M | $683.6K |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.